Inhibition of hepatitis C virus infection by NS5A-specific aptamer

Antiviral Research

Volumn 106, Issue 1, 2014, Pages 116-124

  Yu, Xiaoyan ^a   Gao, Yimin ^a   Xue, Binbin ^a   Wang, Xiaohong ^a   Yang, Darong ^a,b   Qin, Yuwen ^a   Yu, Rong ^a   Liu, Nianli ^a,b   Xu, Li ^c   Fang, Xiaohong ^c   Zhu, Haizhen ^a,b  

^a HUNAN UNIVERSITY   (China)

^b HUNAN CANCER HOSPITAL   (China)

^c INSTITUTE OF CHEMISTRY   (China)

Author keywords

Antivirals; Aptamer; HCV; Mutation; NS5A; Replication

Indexed keywords

ANTIVIRUS AGENT; APTAMER; BETA INTERFERON; CORE PROTEIN; NONSTRUCTURAL PROTEIN 5A; VIRUS RNA; INTERFERON REGULATORY FACTOR; NS-5 PROTEIN, HEPATITIS C VIRUS; VIRUS PROTEIN;

ANTIVIRAL ACTIVITY; ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; DRUG CYTOTOXICITY; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN CELL; IN VITRO STUDY; LIVER CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; PROTEIN PURIFICATION; RNA REPLICATION; VIRUS INFECTIVITY; VIRUS REPLICATION; CYTOTOXICITY; NONHUMAN; VIRUS INHIBITION; ANTAGONISTS AND INHIBITORS; CELL LINE; COMBINATORIAL CHEMISTRY; DRUG EFFECTS; HEPACIVIRUS; ISOLATION AND PURIFICATION; PHYSIOLOGY; VIROLOGY;

ANTIVIRAL AGENTS; APTAMERS, NUCLEOTIDE; CELL LINE; HEPACIVIRUS; HEPATOCYTES; HUMANS; SELEX APTAMER TECHNIQUE; VIRAL NONSTRUCTURAL PROTEINS; VIRUS REPLICATION;

EID: 84899524755     PISSN: 01663542     EISSN: 18729096     Source Type: Journal    
DOI: 10.1016/j.antiviral.2014.03.020     Document Type: Article

References (33)

1. M. Bentham, K. Holmes, S. Forrest, D.J. Rowlands, and N.J. Stonehouse Formation of higher-order foot-and-mouth disease virus 3Dpol complexes is dependent on elongation activity J. Virol. 86 2012 2371 2374
2. K.J. Blight, J.A. McKeating, J. Marcotrigiano, and C.M. Rice High permissive cell lines for subgenomic and genomic hepatitis C virus RNA replication J. Virol. 76 2002 13001 13014
3. M.A. Ditzler, D. Bose, N. Shkriabai, B. Marchand, S.G. Sarafiano, M. Kvaratskhelia, and D.H. Burke Broad-spectrum aptamer inhibitors of HIV reverse transcriptase closely mimic natural substrates Nucleic Acids Res. 39 2011 8237 8247
4. A.D. Ellington, and J.W. Szostak In vitro selection of RNA molecules that binds specific ligands Nature 346 1990 818 822
5. M. Gao, R.E. Nettles, M. Belema, L.B. Snyder, V.N. Nguyen, R.A. Fridell, M.H. Serrano-Wu, D.R. Langley, J.H. Sun, D.R. O'Boyle, J.A. Lemm, C. Wang, J.O. Knipe, C. Chien, R.J. Colonno, D.M. Grasela, N.A. Meanwell, and L.G. Hamann Chemical genetics strategy identifies an HCV NS5A inhibitor with a potent clinical effect Nature 465 2010 96 100
6. P. Halfon, and S. Locarnini Hepatitis C virus resistance to protease inhibitors J. Hepatol. 55 2011 192 206
7. J.H. Hoofnagle, and L.B. Seeff Peginterferon and ribavirin for chronic hepatitis C N. Engl. J. Med. 355 2006 2444 2451
8. M. Hughes, S. Gretton, H. Shelton, D.D. Brown, C.J. McCormick, A.G. Angus, A.H. Patel, S. Griffin, and M. Harris A conserved praline between domain II and III of hepatitis C virus NS5A influences both RNA replication and virus assembly J. Virol. 83 2009 10788 10796
9. S.Y. Hwang, H.Y. Sun, K.H. Lee, B.H. Oh, Y.J. Cha, B.H. Kim, and J.Y. Yoo 5′-Triphosphate- RNA-independent activation of RIG-I via RNA aptamer with enhanced antiviral activity Nucleic Acids Res. 40 2012 2433 2724
10. J. Jiang, and G. Luo Cell culture-adaptive mutations promote viral protein-protein interactions and morphogenesis of infectious hepatitis C virus J. Virol. 86 2012 8987 8997
11. A.D. Keefe, S. Pai, and A. Ellington Aptamers as therapeutics Nat. Rev. Drug Discovery 9 2010 537 550
12. S. Kim, C. Welsch, M. Yi, and S.M. Lemon Regulation of the production of infectious genotype 1a hepatitis C virus by NS5A domain III J. Virol. 85 2011 6645 6656
13. G.M. Laucer, and B.D. Walker Hepatitis C virus infection N. Engl. J. Med. 345 2001 41 52
14. B.D. Lindenbach, M.J. Evans, A.J. Syder, B. Wolk, T.L. Tellinghuisen, C.C. Liu, T. Maruyama, R.O. Hynes, D.R. Burton, J.A. McKeating, and C.M. Rice Complete replication of hepatitis C virus in cell culture Science 309 2005 623 626
15. T. Masaki, R. Suzuki, K. Murakami, H. Aizaki, K. Ishii, A. Murayama, T. Date, Y. Matsuura, T. Miyamura, T. Wakita, and T. Suzuki Interaction of hepatitis C virus nonstructural protein 5A with core protein is critical for the production of infectious virus particles J. Virol. 82 2008 7964 7976
16. M.D. Moore, J. Cookson, V.K. Coventry, B. Sproat, L. Rabe, R.D. Cranston, I. McGowan, and W. James Protection of HIV neutralizing aptamers against rectal and vaginal nucleases: implications for RNA-based therapeutics J. Biol. Chem. 286 2011 2526 2535
17. J.M. Pawlotsky New antiviral agents for hepatitis C. F1000 Biol. Rep. 4 2012 5
18. D. Ramalingam, S. Duclair, S.A.K. Datta, A. Ellington, A. Rein, and V.R. Prasad RNA aptamers directed to human immunodeficiency virus type 1 Gag protein bind to matrix and nucleocapsid domains and inhibit virus production J. Virol. 85 2011 305 314
19. C.M. Rice New insights into HCV replication: potential antiviral targets Top. Antivir. Med. 19 2011 117 120
20. N. Sakamoto, and M. Watanabe New therapeutic approaches to hepatitis C virus J. Gastroenterol. 44 2009 643 649
21. S. Shi, X. Yu, Y. Gao, B. Xue, X. Wu, X. Wang, D. Yang, and H. Zhu Inhibition of hepatitis C virus production by aptamer for core protein J. Virol. 88 2014 1990 1999
22. W. Tan, H. Wang, Y. Chen, X. Zhang, H. Zhu, R. Yang, C.R. Yang, and C. Liu Molecular aptamers for drug delivery Trends Biotechnol. 29 2011 634 640
23. T.L. Tellinghuisen, J. Marcotrigiano, and C.M. Rice Structure of zinc-binding domain of an essential component of the hepatitis virus replicase Nature 435 2005 374 379
24. T. Tellinghuisen, K.L. Foss, J.C. Treadaway, and C.M. Rice Identification of residues required for RNA replication in domains II and III of the hepatitis C virus NS5A protein J. Virol. 82 2008 1073 1083
25. C. Tuerk, and L. Gold Systematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA polymerase Science 249 1990 505 510
26. T. Wakita, T. Pietschmann, T. Kato, T. Date, M. Miyamoto, Z. Zhao, K. Murthy, A. Habermann, H.G. Krausslich, N. Mizokami, R. Bartenschlager, and T.J. Liang Production of infectious hepatitis C virus in tissue culture from a cloned viral genome Nat. Med. 11 2005 791 796
27. L.A. Wheeler, R. Trifonova, V. Vrbanac, E. Basar, S. McKernan, Z. Xu, E. Seung, M. Deruaz, T. Dudek, J.I. Einarsson, L. Yang, T.M. Allen, A.D. Luster, A.M. Tager, D.M. Dykxhoorn, and J. Lieberman Inhibition of HIV transmission in human cervicovaginal explants and humanized mice using C4 aptamer-siRNA chimeras J. Clin. Invest. 121 2011 2401 2412
28. D. Yang, N. Liu, C. Zuo, S. Lei, X. Wu, F. Zhou, C. Liu, and H. Zhu Innate immune response of primary human hepatocytes with hepatitis C viral infection PLoS One 6 2011 e27552
29. D. Yang, B. Xue, X. Wang, X. Yu, N. Liu, Y. Gao, C. Liu, and H. Zhu 2-Octynoic acid inhibits hepatitis C virus infection through activation of AMP-activated protein kinase PLoS One 8 2013 e64932
30. M. Yi, R.A. Villanueva, D.L. Thomas, T. Wakita, and S.M. Lemon Production of infectious genotype 1a hepatitis C virus (Hutchinson strain) in cultured human hepatoma cells Proc. Natl. Acad. Sci. U.S.A. 103 2006 2310 2315
31. J. Zhong, P. Gastaminza, G. Cheng, S. Kapadia, T. Kato, D.R. Burton, S.F. Wieland, S.L. Uprichard, T. Wakita, and F.V. Chisari Robust hepatitis C virus infection in vitro Proc. Natl. Acad. Sci. U.S.A. 102 2005 9294 9299
32. H. Zhu, and C. Liu Interleukin-1 inhibits hepatitis C virus subgenomic RNA replication by activation of extracellular regulated kinase pathway J. Virol. 77 2003 5493 5498
33. H. Zhu, H. Zhao, C.D. Collins, S.E. Eckerrode, Q. Ruan, R.A. McIndoe, J.M. Crawford, D.R. Nelson, J.X. She, and C. Liu Gene expression associated with interferon alfa antiviral activity in an HCV replicon cell line Hepatology 37 2003 1180 1188